Author: Dr. Emily Black Davis, MD - Clinical, Biochemical Genetics, and Rare Diseases Specialist

Dr. Emily Davis Black, MD, is a board-certified clinical geneticist at the Greenwood Genetic Center in Greenville, South Carolina. Since joining the center in July 2022, she has specialized in diagnosing and managing inherited metabolic and genetic disorders, bringing deep expertise in clinical biochemical genetics and genomics to her practice. At Greenwood, Dr. Black works alongside interdisciplinary teams—pediatricians, metabolic specialists, and genetic counselors—to deliver comprehensive care across both pediatric and adult populations. She practices primarily at the Greenville clinic and collaborates closely with colleagues at the center’s Charleston location, reflecting her commitment to making advanced genetic services accessible throughout the region.

A graduate of the University of South Carolina School of Medicine in Columbia, Dr. Black earned her MD in 2014, graduating with honors and demonstrating early promise in human genetics. Following medical school, she completed a rigorous residency in Pediatrics at the University of Virginia Medical Center, where she developed a strong foundation in childhood development, congenital anomalies, and the complexities of pediatric patient care. During her residency, she cultivated a particular interest in metabolic and biochemical genetics, setting the stage for her later specialization and dedicated work with patients who have rare inherited conditions.

To deepen her expertise, Dr. Black pursued advanced fellowship training in Medical Biochemical Genetics at Emory University School of Medicine. As part of Emory’s Department of Human Genetics, she trained under leading experts in metabolic disorders and genomics, engaging in both clinical rotations and laboratory research. There, she managed cases involving lysosomal storage diseases, mitochondrial dysfunction, and newborn screening follow-up, and she became proficient in integrating next-generation sequencing and biochemical assays into patient workups. Her fellowship solidified her ability to translate cutting-edge laboratory techniques into practical, patient-centered care.
med.emory.edu

An active contributor to the scientific community, Dr. Black has authored and co-authored several peer-reviewed publications that advance understanding of rare metabolic and genetic syndromes. Her work includes a case report on anesthetic management in S-adenosylhomocysteine hydrolase deficiency published in A&A Practice, a detailed phenotypic analysis of 3q29 deletion syndrome in the American Journal of Medical Genetics Part A, and functional studies on ATAD3A variants in Genome Medicine. Through these articles, she has highlighted the importance of precise genotype–phenotype correlations and championed personalized diagnostic approaches for improving clinical outcomes in complex genetic conditions.

Board certified by the American Board of Medical Genetics and Genomics in both Clinical Genetics and Genomics and Medical Biochemical Genetics, Dr. Black maintains active medical licenses in South Carolina (2022–2027), Georgia (2017–2023), and Virginia (2014–2017). She regularly mentors medical students, pediatrics residents, and genetic counseling trainees—sharing her passion for genetic medicine, her collaborative approach to patient care, and her commitment to lifelong learning. Outside of her clinical and academic roles, Dr. Black participates in community outreach and continuing education seminars to raise awareness of genetic disorders and underscore the value of early diagnosis in disease management.